Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
Neuroscience drug developer Lundbeck is increasing its scope to epilepsy through the $2.6 billion acquisition of Longboard Prescribed drugs, an ...
Tag: 2.6B
RECOMMENDED
AI in health care needs patient-centered regulation to avoid discrimination, say experts
Credit score: Pixabay/CC0 Public Area A brand new commentary printed within the Journal of the Royal Society of Medication warns...
Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.